This Week Health
SUBSCRIBE NOW to receive top 7 stories daily to your inbox
<--  All Stories

What to expect from medtech in 2024 | McKinsey

February 14, 2024
McKinsey & Company
Summary
2024 medtech predicted to stabilise growth above prepandemic average, focus on profitability and cash flow, continue pace in technological innovation, experience fluctuating growth across geographies, see gen AI adopters gain productivity benefits, maintain M&A deal volumes, and perceive minimal impact on industry growth by GLP-1 drugs. Insights inspired by dialogues with 200 leaders and McKinsey's decade-front medtech research.
Transform Healthcare - One Connection at a Time

© Copyright 2023 Health Lyrics All rights reserved